https://www.neurojams.it/abstract/ridefinizione-dei-sottotipi-di-malattia-profilo-genetico-e-dellemostasi-dei-pazienti-con-sclerosi-multipla-sulla-base-del-carico-lesionale-nelle-aree-di-confine-vascolare/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/analisi-di-risonanza-magnetica-delleffetto-di-un-precoce-utilizzo-di-siponimod-sulla-neuroinfiammazione-e-sulla-progressione-della-malattia-in-pazienti-affetti-da-sclerosi-multipla/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/sclerosi-multipla-e-malattie-mendeliane-studio-di-network-medicine-e-drug-repurposinggianmarco-bellucci/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/asimmetria-retinica-uno-studio-strutturale-e-funzionale-per-indagare-i-processi-neurodegenerativi-delle-vie-ottiche-nella-sclerosi-multipla/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/impatto-dei-disturbi-del-sonno-sulle-funzioni-cognitive-e-sulla-neurodegenerazione-nella-sclerosi-multipla/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/valutazione-dello-stato-nutrizionale-e-aderenza-alla-dieta-mediterranea-in-pazienti-affetti-da-sclerosi-multipla-pediatrica/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/studio-del-potenziale-infiammatorio-delle-polveri-sottili-aerodisperse-nella-sclerosi-multipla/2023-09-28T14:49:52+02:00https://www.neurojams.it/abstract/diffusely-abnormal-white-matter-nella-sm-outcome-clinico-e-possibile-strategia-diagnostica/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/natalizumab-nella-sclerosi-multipla-pediatrica-confronto-longitudinale-con-fingolimod/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/effetti-dellattivita-fisica-e-del-monitoraggio-a-distanza-in-pazienti-affetti-da-sclerosi-multipla/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/disturbi-olfattivi-e-distress-psicologico-nei-pazienti-con-sclerosi-multipla-correlazioni-ed-impatto-sulla-qualita-di-vita-olfattiva/2022-10-31T19:52:10+01:00https://www.neurojams.it/abstract/identification-of-the-pathological-neuronal-cell-death-mechanisms-and-correlates-in-multiple-sclerosis/2023-09-27T11:14:29+02:00https://www.neurojams.it/abstract/the-brain-immune-ecosystem-b-cells-as-drivers-of-psychiatric-manifestations-in-ms/2023-09-27T11:15:01+02:00https://www.neurojams.it/abstract/proteomic-analysis-of-csf-and-serum-in-the-early-stage-of-multiple-sclerosis-and-neuron-elitis-optica-relationship-with-disease-condition-and-out-comes/2023-09-27T11:15:22+02:00https://www.neurojams.it/abstract/identification-of-an-anti-ebv-serological-signature-in-prodromal-and-definite-multiple-sclerosis/2023-09-27T11:15:47+02:00https://www.neurojams.it/abstract/lipidomics-in-multiple-sclerosis-possible-biomarkers-and-future-application/2023-09-27T11:16:07+02:00https://www.neurojams.it/abstract/smoldering-lesions-in-recent-onset-multiple-sclerosis-a-prospective-study/2023-09-27T11:16:26+02:00https://www.neurojams.it/abstract/glymphatic-system-assessment-in-multiple-sclerosis-and-idiopathic-intracranial-hypertension-and-association-with-sleep-function/2023-09-27T11:16:45+02:00https://www.neurojams.it/abstract/network-centrality-and-dynamics-in-cognitively-or-physically-resilient-multiple-sclerosis-patients-a-functional-mri-study/2023-09-27T11:17:02+02:00https://www.neurojams.it/abstract/understanding-different-neuroradiological-profiles-between-ms-patients-positive-and-negative-for-anti-mog-antibodies-a-retrospective-cohort-study/2023-09-28T14:48:18+02:00https://www.neurojams.it/abstract/estimation-of-age-in-multiple-sclerosis-lesions-from-magnetic-resonance-imaging-stage-les/2023-09-28T12:41:37+02:00https://www.neurojams.it/abstract/opportunities-for-action-irvestigating-body-representation-and-body-space-interaction-in-multiple-sclerosis/2023-09-28T14:44:07+02:00https://www.neurojams.it/abstract/the-impact-of-epilepsy-on-multiple-sclerosis-from-a-clinical-and-radiological-perspective/2023-09-28T14:44:24+02:00https://www.neurojams.it/abstract/assessing-melanoma-susceptibility-among-multiple-sclerosis-patients-under-various-disease-modifying-therapies/2023-09-28T14:44:42+02:00https://www.neurojams.it/abstract/centro-later-al-thalamic-nucleus-ablation-through-magnetic-resonance-guided-focused-ultrasound-in-the-treatment-of-resistant-neuropathic-pain-in-ms-patients/2023-09-28T14:45:01+02:00https://www.neurojams.it/abstract/a-comprehensive-overview-of-social-determinants-of-health-among-patients-with-multiple-sclerosis-in-italy/2023-09-28T14:45:18+02:00https://www.neurojams.it/abstract/impact-of-ntz-treatment-on-nfl-levels-during-pregnancy-in-multiple-sclerosis-a-retrospective-analysis/2023-09-28T14:45:33+02:00https://www.neurojams.it/abstract/teleriabilitazione/2023-09-28T15:42:17+02:00https://www.neurojams.it/abstract/ricerca-di-marcatori-prognostici-in-sm-il-punto-di-vista-genetico/2023-09-28T15:42:10+02:00https://www.neurojams.it/abstract/meccanismo-di-innesco-mediato-dal-nontypeable-haemophilus-influenzae-nella-sm/2023-09-28T15:42:02+02:00https://www.neurojams.it/abstract/wearable-devices/2023-09-28T15:41:57+02:00https://www.neurojams.it/abstract/eccitabilita-corticale-e-destrezza-manuale-nella-sm-pp/2023-09-28T15:41:52+02:00https://www.neurojams.it/abstract/extended-interval-dosing-nella-terapia-con-natalizumab/2023-09-28T15:41:47+02:00https://www.neurojams.it/abstract/nuove-metodiche-di-pet-nella-sm/2023-09-28T15:41:41+02:00https://www.neurojams.it/abstract/gadolinio-valore-aggiunto-o-rischio-evitabile/2023-09-28T15:41:36+02:00https://www.neurojams.it/abstract/genitorialita-e-sm/2023-09-28T15:41:27+02:00https://www.neurojams.it/abstract/slowly-evolving-lesions-sel-nella-sclerosi-multipla/2023-09-28T15:41:21+02:00https://www.neurojams.it/abstract/slowly-evolving-lesions-sel-nella-sclerosi-multipla-2/2023-09-28T15:41:17+02:00https://www.neurojams.it/abstract/evaluating-the-efficacy-of-an-adapted-physical-activity-program-on-clinical-outcomes-in-multiple-sclerosis-a-prospective-study/2024-10-04T12:51:12+02:00https://www.neurojams.it/abstract/investigating-the-association-between-hyperreflective-foci-hrf-and-paramagnetic-rim-lesions-prl-in-multiple-sclerosis-an-oct-mri-study-of-cerebral-microglia-activation/2024-10-04T12:51:56+02:00https://www.neurojams.it/abstract/characterization-of-grey-matter-damage-with-soma-and-neurite-density-imaging-metrics-in-multiple-sclerosis-and-its-correlation-with-disability/2024-10-04T12:52:32+02:00https://www.neurojams.it/abstract/hlas-an-old-new-way-to-understand-and-individualize-treatment-response/2024-10-04T12:52:50+02:00https://www.neurojams.it/abstract/interrogation-of-multiple-sclerosis-prodromes-using-digital-health-data-a-retrospective-prospective-observational-study/2024-10-04T12:53:08+02:00https://www.neurojams.it/abstract/sleep-disorders-in-multiple-sclerosis-implication-for-motor-and-cognitive-decline/2024-10-04T12:53:27+02:00https://www.neurojams.it/abstract/enhancing-ms-diagnosis-leveraging-deep-learning-to-classify-lesions-using-standard-mri-sequences/2024-10-04T12:53:46+02:00https://www.neurojams.it/abstract/is-neda3-enough-in-multiple-sclerosis-a-longitudinal-study-inlcuding-plasma-neurofilament-light-chain-in-neda3-definition/2024-10-04T12:54:04+02:00https://www.neurojams.it/abstract/leptomeningeal-inflammation-and-synaptic-pathology-in-multiple-sclerosis-cortex/2024-10-25T18:05:26+02:00https://www.neurojams.it/abstract/role-of-rna-binding-protein-hur-in-the-pathogenesis-and-rate-of-progression-of-multiple-sclerosis/2024-10-04T12:55:35+02:00https://www.neurojams.it/abstract/unveiling-the-spectrum-of-cognitive-decline-in-ms-beyond-the-binary/2024-10-04T12:55:47+02:00https://www.neurojams.it/abstract/considering-dmt-discontinuation-in-older-patients-with-multiple-sclerosis-who-when-and-how/2024-10-04T12:56:03+02:00